Intelligence and Neurodevelopmental Disorders After Prenatal Exposure to General Anaesthesia
NCT ID: NCT06633406
Last Updated: 2026-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
192 participants
OBSERVATIONAL
2024-10-14
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The goal of this cohort study is to compare the intelligence and neurodevelopmental outcome of children prenatally exposed to general anaesthesia for maternal abdominal surgery with those of unexposed children and with those of children prenatally exposed to maternal inflammation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurodevelopmental Outcome After Prenatal Anesthesia
NCT06052878
General Anesthesia Exposure and Neurodevelopmental Outcome in Pediatrics
NCT04604106
Neurodevelopment of Infants Exposed to General Anesthesia: a Multi-center Investigation
NCT03629093
Neuraxial Labor Analgesia and Offspring Neurodevelopment
NCT04964206
Cerebral Oxymetry and Neuronal Markers in Newborns and Infants Undergoing Surgery
NCT02423369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prenatal Anaesthesia Exposure
Children exposed in utero to maternal general anaesthesia to allow laparoscopy or laparotomy for appendicectomy, adnexal pathology, cholecystectomy or for diagnostic procedures to rule out intra-abdominal pathology
Age-appropriate Wechsler Intelligence Test
2.5-6 years: Wechsler Preschool and Primary Scale of Intelligence for children (WPPSI IV)
7-16 years: Wechsler Intelligence Scale for Children (WISC V)
\>17 years: Wechsler Adult Intelligence Scale (WAIS IV)
Disruptive Behavior Disorders Rating Scale
Dutch version of the Disruptive Behavior Disorders Rating Scale
Social Responsiveness Scale
3-18 years: social responsiveness scale 2 (SRS-2)
\>19 years: Social Responsiveness Scale - Adult version (SRS-A)
No Prenatal Anaesthesia Exposure
Children not exposed to general anaesthesia for non-obstetric or obstetric (e.g. cesarean section) surgery in utero
Age-appropriate Wechsler Intelligence Test
2.5-6 years: Wechsler Preschool and Primary Scale of Intelligence for children (WPPSI IV)
7-16 years: Wechsler Intelligence Scale for Children (WISC V)
\>17 years: Wechsler Adult Intelligence Scale (WAIS IV)
Disruptive Behavior Disorders Rating Scale
Dutch version of the Disruptive Behavior Disorders Rating Scale
Social Responsiveness Scale
3-18 years: social responsiveness scale 2 (SRS-2)
\>19 years: Social Responsiveness Scale - Adult version (SRS-A)
Prenatal exposure to maternal inflammation
Children prenatally exposed to maternal inflammation, specifically those born to mothers with inflammatory bowel disease (IBD)
Age-appropriate Wechsler Intelligence Test
2.5-6 years: Wechsler Preschool and Primary Scale of Intelligence for children (WPPSI IV)
7-16 years: Wechsler Intelligence Scale for Children (WISC V)
\>17 years: Wechsler Adult Intelligence Scale (WAIS IV)
Disruptive Behavior Disorders Rating Scale
Dutch version of the Disruptive Behavior Disorders Rating Scale
Social Responsiveness Scale
3-18 years: social responsiveness scale 2 (SRS-2)
\>19 years: Social Responsiveness Scale - Adult version (SRS-A)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Age-appropriate Wechsler Intelligence Test
2.5-6 years: Wechsler Preschool and Primary Scale of Intelligence for children (WPPSI IV)
7-16 years: Wechsler Intelligence Scale for Children (WISC V)
\>17 years: Wechsler Adult Intelligence Scale (WAIS IV)
Disruptive Behavior Disorders Rating Scale
Dutch version of the Disruptive Behavior Disorders Rating Scale
Social Responsiveness Scale
3-18 years: social responsiveness scale 2 (SRS-2)
\>19 years: Social Responsiveness Scale - Adult version (SRS-A)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No prenatal anaesthesia exposure: Children not exposed to general anaesthesia for non-obstetric or obstetric (e.g. cesarean section) surgery in utero
* Children exposed to inflammation: Children born to mothers diagnosed with inflammatory bowel disease (IBD) who had a flare-up during pregnancy without being exposed to general anaesthesia for non-obstetric or obstetric (e.g. cesarean section) surgery in utero.
* Children born in 2000-2023
* (Parental) informed consent
Exclusion Criteria
* No Dutch-speaking children
* Diagnosis of severe disability of genetic origin (e.g., Fragil X, Down syndrome,…), history of head trauma, major congenital birth defects
2 Years
27 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Devroe, MD, Phd
Role: PRINCIPAL_INVESTIGATOR
UZ Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imeldaziekenhuis
Bonheiden, Antwerpen, Belgium
UZ Leuven
Leuven, Vlaams-Brabant, Belgium
AZ Delta
Roeselare, West-Flanders, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S68647
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.